Arine Raises $11M to Scale AI-Driven Medication Optimization Platform
Summary
What You Should Know: – Arine, a San Francisco-based AI-driven platform that optimizes medication management, reduces costs and improves outcomes for health plans and providers today announced that it closed $11 million in an oversubscribed Series A round co-led by 111° West Capital Partners and Katalyst Ventures, with strategic investments from Magellan Health Inc. and SCAN Group. Arine optimizes medication therapy and treatment plans – saving 1 in every 6 healthcare dollars spent. The platform’s thousands of algorithms intake and analyze multi-source data to recommend just-in-time clinical interventions for each individual patient at their point of need. These timely interventions reduce the total cost of care and drive a significant ROI for healthcare organizations. – Arine plans to use the latest round of funding to rapidly scale its team and its technology platform from the 5.5M lives actively managed today.